Y. Liu, S. Qiu, J. Yu et al.
Tetrahedron 81 (2021) 131869
7.35e7.27 (m, 2H). 13C NMR (126 MHz, CDCl3)
139.97, 139.75, 133.48, 133.18, 129.57, 129.50, 129.28, 127.86, 127.68,
127.09, 126.33, 123.96, 120.93, 120.54, 109.61.
d
142.47, 141.38,
(d, J ¼ 8.2 Hz, 2H), 7.72 (d, J ¼ 8.6 Hz, 2H), 7.44 (dd, J ¼ 8.8, 1.6 Hz,
4H), 7.28e7.32 (m, 6H), 2.40 (s, 3H), 1.45 (s, 36H).
3.6. 3,6-di-tert-butyl-9-(3-(3,6-di-tert-butyl-9H-carbazol-9-yl)-
9H-carbazol-6-yl)-9H-carbazole (5)
3.2. 3,6-di-tert-butyl-9H-carbazole (1)
Carbazole (5.016 g, 30 mmol), AlCl3 (4.0 g, 30 mmol) and CH2Cl2
KOH (0.13 g, 2.32 mmol) is added to a 100 mL round-bottom
flask, and a solution of 4 (1.0 g, 1.14 mmol) in DMSO (6 mL)、THF
(12 mL) and water (2 mL) is added, then the mixture is stirred and
refluxed for 1.5 h. After cooling to room temperature, adding 10%
HCl (20 mL), then adding water (10 mL) and methanol (5 mL). After
filtration, the precipitate is collected and rinsed with water. The
crude product is purified by column chromatography on silica gel
with eluent: petroleum ether/CH2Cl2 to yield 5 (0.68 g, 76%) as a
(120 mL) are added to a 100 mL round-bottom flask. After cooling to
0
ꢁC, tert-butyl chloride (7.5 ml 60 mmol) is placed in CH2Cl2
(20 ml) and added dropwise for 20 min to form a dark yellow so-
lution. The mixture is stirred at 0 ꢁC for 1 h and at room temper-
ature for 9 h, then pour into ice water and extracted with CH2Cl2.
The combined organic phase is washed with water, brine, dried
over anhydrous NaSO4, filtered, and concentrated under reduced
pressure. The crude product is purified by column chromatography
on silica gel with petroleum ether/CH2Cl2 to yield 1 (0.87 g, 65%) as
white solid. 1H NMR (500 MHz, CDCl3):
d 8.40 (s, 1H), 8.17 (d,
J ¼ 4.8 Hz, 6H), 7.66 (d, J ¼ 8.7 Hz, 2H), 7.58 (d, J ¼ 8.6 Hz, 2H), 7.43
a white powder. 1H NMR (500 MHz, CDCl3):
d
8.07 (d, J ¼ 1.8 Hz,
(d, J ¼ 8.6 Hz, 4H), 7.11 (d, J ¼ 8.6 Hz, 4H), 1.45 (s, 36H).
2H), 7.84 (s, 1H), 7.45 (d, J ¼ 8.2 Hz, 2H), 7.31 (d, J ¼ 8.6 Hz, 2H), 1.44
(s, 18H).
3.7. 3,6-di-tert-butyl-9-(3-(3,6-di-tert-butyl-9H-carbazol-9-yl)-9-
(4-(phenylsulfonyl)phenyl)-9H-carbazol-6-yl)-9H-carbazole (t3Cz-
SO)
3.3. 3,6-diiodo-9H-carbazole (2)
Carbazole (1.00 g, 5.98 mmol), acetic acid (16 mL) are added to a
100 mL round-bottom flask and the solution is heated to 50 ꢁC.
Then KI (1.29 g, 7.77 mmol) is added. After stirring for a few mi-
nutes, a solution of KIO3 (1.279 g, 5.98 mmol) in acetic acid (2 mL) is
added dropwise. After the mixture is refluxed for 1 h, a light red
suspension is obtained. After cooling to room temperature, adding
water and extracted with CH2Cl2. The obtained organic phase is
washed with water, brine, and dried over anhydrous NaSO4, then
filtered, and concentrated. The crude product is purified by column
chromatography on silica gel with ethyl acetate/petroleum ether to
yield 2 (0.87 g, 65%) as a red-brown powder. 1H NMR (500 MHz,
1-bromo-4-(phenylsulfonyl)benzene (0.2 g, 1 mmol), 5 (0.53 g,
1.1 mmol), K2CO3 (0.28 g, 3 mmol), CuI (0.025 g, 0.2 mmol), 1,10-
Phenant-hroline hydrate (0.027 g, 0.2 mmol) are added to a
100 mL round-bottom flask, and then DMF (20 mL) is added under a
nitrogen atmosphere. After stirring for 24 h at 110 ꢁC, the reaction
mixture is cooled to room temperature. The solvent is removed
under reduced pressure and the mixture is extracted with CH2Cl2
and water. The organic extracts are combined, and dried over
Na2SO4. The crude product is purified by column chromatography
on silica gel with eluent: petroleum ether/ethyl acetate to yield M2
(0.84 g, 62%) as a white solid. 1H NMR (500 MHz, CDCl3):
d 8.46 (d,
CDCl3):
2H), 7.21 (d, J ¼ 8.4 Hz, 2H).
d
8.32 (d, J ¼ 1.8 Hz, 2H), 8.10 (s, 1H), 7.66 (dd, J ¼ 8.2, 1.6 Hz,
J ¼ 8.6 Hz, 2H), 8.29 (d, J ¼ 1.6 Hz, 2H), 8.20 (d, J ¼ 1.2 Hz, 4H), 8.06
(d, J ¼ 8.6 Hz, 2H), 7.77 (d, J ¼ 8.7 Hz, 2H), 7.68 (dd, J ¼ 8.7, 1.8 Hz,
2H), 7.65e7.55 (m, 5H), 7.49 (dd, J ¼ 8.6, 1.6 Hz, 4H), 7.36 (d,
3.4. 3,6-diiodo-9-tosyl-9H-carbazole (3)
J ¼ 8.6 Hz, 4H), 1.50 (s, 36H). 13C NMR (126 MHz, CDCl3)
d 142.82,
142.40, 140.10, 139.98, 139.43, 131.98, 130.17, 127.48, 126.32, 124.77,
123.67, 123.26, 119.54, 116.34, 111.03, 108.99, 77.31, 77.06, 76.80,
53.46, 34.78, 32.06.
To a solution of 2 (1.5 g, 3.58 mmol) and KOH (0.92 g, 16.4 mmol)
in acetone (20 mL) is slowly added p-toluenesulfonyl chloride
(3.127 g, 16.4 mmol) in acetone (2 mL). After refluxing for 15 min,
the reaction solution is poured into water and extracted with
CH2Cl2. The obtained organic phase is washed with water and
brine, dried over anhydrous NaSO4, and finally filtered and
concentrated. The crude product is purified by column chroma-
tography on silica gel with petroleum ether/CH2Cl2 to yield 3
(1.23 g, 63%) as a red-brown powder. 1H NMR (500 MHz, CDCl3):
4. Result and discussion
4.1. Thermal Properties
The thermal stability of Cz-SO and t3Cz-SO in solid powder state
is tested by thermogravimetric analysis (TGA) and differential
scanning calorimetry (DSC), as shown in Fig. 1. The TGA curve
shows that the decomposition temperatures (Td, corresponding to
5% weight loss) of Cz-SO and t3Cz-SO are 278 ꢁC and 513 ꢁC,
respectively. The high thermal stability indicates that t3Cz-SO has
higher thermal stability than Cz-SO. The DSC curve exhibits that the
glass transition temperature (Tg) of Cz-SO is 152 ꢁC, while t3Cz-SO
has no obvious glass transition temperature in the range of
25e200 ꢁC. This means that t3Cz-SO will not undergo any
morphological changes during the annealing process, which is
more advantageous to the spin-coating method for preparing OLED
devices.
In order to further verify the film-forming ability of the com-
pounds and the morphologies of the solution-processed films, the
atomic force microscopy (AFM) measurement was tested under
non-contact mode. The Cz-SO and t3Cz-SO are prepared with 1, 2-
dichloroethane solution (10 mg/mL), then spin-coated on the ITO/
PEDOT: PSS substrate at a speed of 2000 rpm. Fig. 2 shows the
measured surface morphology of these two compounds after spin-
d
8.17 (d, J ¼ 1.2 Hz, 2H), 8.07 (d, J ¼ 8.6 Hz, 2H), 7.76 (d, J ¼ 8.6 Hz,
2H), 7.63 (d, J ¼ 8.4 Hz, 2H), 7.11 (d, J ¼ 7.8 Hz, 2H), 2.27 (s, 3H).
3.5. 3,6-di-tert-butyl-9-(3-(3,6-di-tert-butyl-9H-carbazol-9-yl)-9-
tosyl-9H-carbazol-6-yl)-9H-carbazole (4)
CuI (0.29 g, 1.5 mmol), K3PO4 (1.592 g, 7.5 mmol), and ( )-trans-
1,2- diaminocycl-ohexane (DACH, 0.2 mL, 1.6 mmol) are added to a
100 mL round-bottom flask. Then adding a solution of 3 (1.72 g,
3 mmol) and 1 (1.85 g, 6.6 mmol) in toluene (40 mL). The above
mixture is refluxed and stirred for 24 h. After cooling to room
temperature, water and CH2Cl2 are added for extraction. The ob-
tained organic phase is washed with water and brine successively,
and finally dried with anhydrous Na2SO4, then filtered and
concentrated. The crude product is purified by column chroma-
tography on silica gel with eluent: petroleum ether/CH2Cl2 to yield
4 (0.78 g, 56%) as a white solid. 1H NMR (500 MHz, CDCl3):
J ¼ 8.2 Hz, 2H), 8.14 (d, J ¼ 1.8 Hz, 4H), 8.02 (d, J ¼ 1.6 Hz, 2H), 7.90
d 8.56 (d,
3